OHSU is first in Oregon to offer new prostate cancer treatment option
April 21, 2025
Robotic-assisted high-frequency focused ultrasound targets cancerous tissue while minimizing side effects.
Stories
Un descubrimiento revela que una proteína implicada en la enfermedad de Parkinson también impulsa el cáncer de piel
April 09, 2025
Diferentes comportamientos de la misma proteína clave en neuronas y células de la piel sugieren que nuevas terapias deberían dirigirse a la proteína alfa sinucleína.
Clinical trial shows promising results for boosting colorectal cancer screening in rural areas
March 17, 2025
With more than 5,600 Medicaid enrollees in rural Oregon, the study addresses low screening rates.
OHSU study confirms link between breast density, higher breast cancer risk
March 10, 2025
Risk of developing breast cancer is 1.7 times higher for women with dense breasts.
New blood test identifies hard-to-detect pancreatic cancer with 85% accuracy
February 12, 2025
Called PAC-MANN, the test developed at OHSU could help save lives.
OHSU awarded $1.4 million for new cancer drug development training program
February 04, 2025
NIH grant funds immersive program to give M.D., Ph.D. postdoctoral fellows hands-on training in cancer drug development.
OHSU researchers use AI machine learning to map hidden molecular interactions in bacteria
January 24, 2025
‘Discovery-driven science leading to real-world applications’: Study opens new pathways for cancer research, treatments.
Logros de OHSU en el 2024: un repaso del año
December 31, 2024
A pesar de los desafíos, el año pasado estuvo marcado por descubrimientos significativos, atención médica transformadora y la expansión de programas educativos.
OHSU 2024 accomplishments: The year in review
December 31, 2024
Despite challenges, past year marked by significant discoveries, life-changing patient care, expanding educational programs.
Imagenología en OHSU: los científicos usan imagenología avanzada en la lucha contra el cáncer
November 22, 2024
En OHSU Knight Cancer Institute, el paciente es una prioridad en el avance hacia la detección e intervención tempranas del cáncer.
